相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential Therapeutic Targets in Plasma Cell Disorders: A Flow Cytometry Study
Katharina Lisenko et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens
Tilmann Bochtler et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Amyloidosis: A Clinical Overview
Bouke P. C. Hazenberg
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients
Stefan O. Schoenland et al.
BLOOD (2012)
Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis
S. O. Schoenland et al.
BONE MARROW TRANSPLANTATION (2012)
AL Amyloidosis
Estelle Desport et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
Tilmann Bochtler et al.
BLOOD (2011)
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis
Bruno Paiva et al.
BLOOD (2011)
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Meletios Dimopoulos et al.
BLOOD (2011)
Pitfalls in the Diagnosis of Primary Amyloidosis
Cheng E. Chee et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Immunophenotype of neoplastic plasma cells in AL amyloidosis
M. Deshmukh et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces aritibody-dependent cellular cytotoxicity in the bone marrow mitieu
Yu-Tzu Tai et al.
BLOOD (2008)
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome
Ashutosh D. Wechalekar et al.
BLOOD (2008)
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
Tilmann Bochtler et al.
HAEMATOLOGICA (2008)
The clinical spectrum of IgM-Related amyloidosis - A French mnationwide retrospective study of 72 patients
Benjamin Terrier et al.
MEDICINE (2008)
AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes
V. Sanchorawala et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
CD52 antigen expressed by malignant plasma cells can be targeted by alerntuzumab in vivo in NOD/SCID mice
Carmelo Carlo-Stella et al.
EXPERIMENTAL HEMATOLOGY (2006)
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
S Wuilleme et al.
LEUKEMIA (2005)
Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association
AD Cohen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Bone marrow core biopsy specimens in AL (primary) amyloidosis - A morphologic and immunohistochemical study of 100 cases
N Swan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
T(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
R Garand et al.
LEUKEMIA (2003)
Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis
M Matsuda et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
分享论文
